THORNBURG INVESTMENT MANAGEMENT INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
THORNBURG INVESTMENT MANAGEMENT INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2022$13,591,000
+17.6%
214,973
-1.3%
0.18%
+31.9%
Q4 2021$11,556,000
-33.2%
217,874
-11.1%
0.14%
-36.3%
Q3 2021$17,305,000
+5.3%
245,143
-0.6%
0.21%
+12.2%
Q2 2021$16,432,000
-13.0%
246,575
+44.9%
0.19%
-13.7%
Q1 2021$18,889,000
-44.0%
170,153
-40.1%
0.22%
-45.2%
Q4 2020$33,742,000
+81.7%
284,147
+33.5%
0.40%
+63.3%
Q3 2020$18,566,000212,7920.24%
Other shareholders
HAEMONETICS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders